236 results
Page 4 of 12
8-K
EX-99.1
3rg smvdw
17 Oct 22
Clinical trial anticipated to begin in late 2022
4:02pm
425
5kvshzrr
13 Oct 22
Business combination disclosure
4:03pm
8-K
ikuiy8bhn 4r8e3e4rhd
13 Oct 22
Kineta to Present Anti-CD27 Agonist Preclinical Program at AACR Conference on Tumor Immunology and Immunotherapy
4:01pm
8-K
EX-99.1
gb7 anavbca
13 Oct 22
Kineta to Present Anti-CD27 Agonist Preclinical Program at AACR Conference on Tumor Immunology and Immunotherapy
4:01pm
425
s1g oyxjxys7a0dc
11 Oct 22
Business combination disclosure
8:02am
8-K
clmvrgy2 sfsaht4
11 Oct 22
Kineta Announces Participation in Upcoming October 2022 Investor Conferences
8:00am
8-K
EX-99.1
hmszc8ps2
11 Oct 22
Kineta Announces Participation in Upcoming October 2022 Investor Conferences
8:00am
425
3st3rd6s9rstcw
4 Oct 22
Business combination disclosure
4:04pm
8-K
EX-99.1
hwuyxirq f0bmp47
4 Oct 22
Kineta Appoints Keith Baker as Chief Financial Officer
4:01pm
8-K
xtq6ezxh 889vegar
4 Oct 22
Kineta Appoints Keith Baker as Chief Financial Officer
4:01pm